| [1] |
ZHOU Wanyu, ZHAO Chuanjing, ZHANG Xueyan, WU Weizhi.
Dupilumab in the treatment of acquired reactive perforating collagenosis: a case report and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(6): 432-436.
|
| [2] |
HE Jing, HUANG Xiaohui, ZHU Zimo, DOU Xia.
Dupilumab for the treatment of Hailey-Hailey disease: a case report and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(3): 203-205.
|
| [3] |
SHAO Yuling, WANG Na.
Successful treatment of dupilumab-associated nail psoriasis with upadacitinib: a case report and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(3): 206-210.
|
| [4] |
WANG Sha, CHEN Xiaoqiang.
Dupilumab for the treatment of pruriginous dystrophic epidermolysis bullosa: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(3): 214-215.
|
| [5] |
HUANG Jingran, WANG Lei, FANG Linglu, ZHOU Ying.
Dupilumab in the treatment of pemphigoid gestationis: a case report and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(2): 101-105.
|
| [6] |
WEI Yanjie, ZHANG Lu, CHUAN Jintao, ZHANG Peilian.
Treatment of epidermolysis bullosa acquisita with dupilumab in a child: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(2): 116-118.
|
| [7] |
BI Zhixia, HAN Jindou.
Dupilumab versus abrocitinib in the treatment of atopic dermatitis: a meta-analysis of efficacy and safety
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(1): 5-10.
|
| [8] |
SUN Yanhong, ZHAO Qing, ZHOU Jun, ZHANG Furen.
Successful treatment of eosinophilic pustular folliculitis with dupilumab: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(3): 202-203.
|
| [9] |
ZHANG Xueyan, ZHOU Guizhi, LIU Yongxia, CHEN Shengli.
Clinical and pathological analysis of 4 cases with folliculotropic mycosis fungoides
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(2): 108-112.
|
| [10] |
LAI Meiyan, LONG Boquan, YE Zhiming, LONG Qi, YANG Lan, YOU Furong, GUO Hongwei.
Primary cutaneous amyloidosis successfully treated with dupilumab: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(2): 120-122.
|
| [11] |
CHEN Yubao, ZHANG Tao, YIN Dong, REN Shangli.
Efficacy of tripterygium glycosides wilfordii combined with dupilumab in the treatment of atopic dermatitis
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(11): 797-800.
|
| [12] |
WEI Yanjie, REN Rujiao, ZHANG Lu, ZHANG Peilian.
Dupilumab in the treatment of atopic dermatitis complicated by keloid: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(11): 821-823.
|
| [13] |
Dilinuer TAXIMAIMAITI, Palida ABULIZI.
Efficacy and safety of abrocitinib and dupilumab in the treatment of moderate to severe atopic dermatitis
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(8): 533-537.
|
| [14] |
WANG Wansi, SHEN Jiaqing, LIU Yi.
Update of TIGIT and related skin diseases
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(5): 377-382.
|
| [15] |
HAN Jinghong, LIU Hong.
Two children with refractory atopic dermatitis successfully treated with Janus kinase inhibitors
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 190-192.
|